Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Szyf

Showing results (71-80 of 256) with videos related to

Pageof 26
Sort By:
British Journal of Pharmacology|August 20, 2014
DNA demethylation and invasive cancer: implications for therapeuticsDavid Cheishvili, Lisa Boureau, Moshe Szyf
The Journal of Biological Chemistry|April 4, 2002
Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modificationSnezana Milutinovic, Qianli Zhuang, Moshe Szyf
Carcinogenesis|December 25, 2004
Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cellsPouya Pakneshan, Moshe Szyf, Shafaat A Rabbani
Cancer Letters|June 29, 2004
DNA demethylation and cancer: therapeutic implicationsMoshe Szyf, Pouya Pakneshan, Shafaat A Rabbani
Environmental and Molecular Mutagenesis|December 21, 2007
The social environment and the epigenomeMoshe Szyf, Patrick McGowan, Michael J Meaney
Biology of Reproduction|January 24, 2014
Adult glucocorticoid exposure leads to transcriptional and DNA methylation changes in nuclear steroid receptors in the hippocampus and kidney of mouse male offspringSophie Petropoulos, Stephen G Matthews, Moshe Szyf
Advances in Experimental Medicine and Biology|September 9, 2011
Role of epigenetics in cancer initiation and progressionFlora Chik, Moshe Szyf, Shafaat A Rabbani
Carcinogenesis|December 23, 2003
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivoPaul M Campbell, Veronica Bovenzi, Moshe Szyf
Biochemical Pharmacology|August 18, 2004
DNA methylation and breast cancerMoshe Szyf, Pouya Pakneshan, Shafaat A Rabbani
Current Cancer Drug Targets|November 25, 2005
Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implicationsPouya Pakneshan, Moshe Szyf, Shafaat A Rabbani
Pageof 26

Showing results (71-80 of 256) with videos related to

Sort By:
Pageof 26
British Journal of Pharmacology|August 20, 2014
DNA demethylation and invasive cancer: implications for therapeuticsDavid Cheishvili, Lisa Boureau, Moshe Szyf
The Journal of Biological Chemistry|April 4, 2002
Proliferating cell nuclear antigen associates with histone deacetylase activity, integrating DNA replication and chromatin modificationSnezana Milutinovic, Qianli Zhuang, Moshe Szyf
Carcinogenesis|December 25, 2004
Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cellsPouya Pakneshan, Moshe Szyf, Shafaat A Rabbani
Cancer Letters|June 29, 2004
DNA demethylation and cancer: therapeutic implicationsMoshe Szyf, Pouya Pakneshan, Shafaat A Rabbani
Environmental and Molecular Mutagenesis|December 21, 2007
The social environment and the epigenomeMoshe Szyf, Patrick McGowan, Michael J Meaney
Biology of Reproduction|January 24, 2014
Adult glucocorticoid exposure leads to transcriptional and DNA methylation changes in nuclear steroid receptors in the hippocampus and kidney of mouse male offspringSophie Petropoulos, Stephen G Matthews, Moshe Szyf
Advances in Experimental Medicine and Biology|September 9, 2011
Role of epigenetics in cancer initiation and progressionFlora Chik, Moshe Szyf, Shafaat A Rabbani
Carcinogenesis|December 23, 2003
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivoPaul M Campbell, Veronica Bovenzi, Moshe Szyf
Biochemical Pharmacology|August 18, 2004
DNA methylation and breast cancerMoshe Szyf, Pouya Pakneshan, Shafaat A Rabbani
Current Cancer Drug Targets|November 25, 2005
Hypomethylation of urokinase (uPA) promoter in breast and prostate cancer: prognostic and therapeutic implicationsPouya Pakneshan, Moshe Szyf, Shafaat A Rabbani
Pageof 26